American Journal of Respiratory and Critical Care Medicine

Rationale: Acute cellular rejection (ACR) after lung transplant is a leading risk factor for chronic lung allograft dysfunction. Prior studies have demonstrated dynamic microbial changes occurring within the allograft and gut that influence local adaptive and innate immune responses. However, the lung microbiome’s overall impact on ACR risk remains poorly understood.

Objectives: To evaluate whether temporal changes in microbial signatures were associated with the development of ACR.

Methods: We performed cross-sectional and longitudinal analyses (joint modeling of longitudinal and time-to-event data and trajectory comparisons) of 16S rRNA gene sequencing results derived from lung transplant recipient lower airway samples collected at multiple time points.

Measurements and Main Results: Among 103 lung transplant recipients, 25 (24.3%) developed ACR. In comparing samples acquired 1 month after transplant, subjects who never developed ACR demonstrated lower airway enrichment with several oral commensals (e.g., Prevotella and Veillonella spp.) than those with current or future (beyond 1 mo) ACR. However, a subgroup analysis of those who developed ACR beyond 1 month revealed delayed enrichment with oral commensals occurring at the time of ACR diagnosis compared with baseline, when enrichment with more traditionally pathogenic taxa was present. In longitudinal models, dynamic changes in α-diversity (characterized by an initial decrease and a subsequent increase) and in the taxonomic trajectories of numerous oral commensals were more commonly observed in subjects with ACR.

Conclusions: Dynamic changes in the lower airway microbiota are associated with the development of ACR, supporting its potential role as a useful biomarker or in ACR pathogenesis.

Correspondence and requests for reprints should be addressed to Jake G. Natalini, M.D., M.Sc., New York University Grossman School of Medicine, 530 First Avenue, Health Care Center (HCC) Suite 4A, New York, NY 10016. E-mail: .

Supported by National Institute of General Medical Sciences grant R21 GM147800 (L.N.S.), National Cancer Institute grant R37 CA244775 (L.N.S.), a Stony Wold-Herbert Fund, Inc. Grant-in-Aid award (J.G.N.), and U.S. National Library of Medicine grant R01 LM014085 (H.L.).

Author Contributions: J.G.N., B.G.W., L.F.A., and L.N.S. contributed to the study’s conception and design, the acquisition of data, and the analysis and interpretation of data. K.K.W., N.C.N., C.W., H.L., I.J.M., T.M., F.D., I.S., M.C.K., C.R.B., J.-C.J.T., S.B.B., and S.S. contributed to the analysis and interpretation of data. D.R., M.B.L., S.Q., T.C.L., A.W., S.H.C., J.C.Y.C., T.C.G., Y.L., P.P., J.S., R.S., D.E.C., M.C., S.P., Y.K., C.M., and H.I.P. contributed to the acquisition of data. J.G.N. generated a first draft of the manuscript. All authors subsequently revised the manuscript for important intellectual content and provided final approval of the version to be published.

This article has a related editorial.

A data supplement for this article is available via the Supplements tab at the top of the online article.

Originally Published in Press as DOI: 10.1164/rccm.202309-1551OC on February 15, 2024

Author disclosures are available with the text of this article at www.atsjournals.org.

Comments Post a Comment




New User Registration

Not Yet Registered?
Benefits of Registration Include:
 •  A Unique User Profile that will allow you to manage your current subscriptions (including online access)
 •  The ability to create favorites lists down to the article level
 •  The ability to customize email alerts to receive specific notifications about the topics you care most about and special offers
American Journal of Respiratory and Critical Care Medicine
209
12

Click to see any corrections or updates and to confirm this is the authentic version of record